Author

F. Kinose

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Assay:proteomics· 1

Frequent Co-Authors

U. Rix· 2 shared A. E. Gaspar-Maia· 1 shared A. Karsan· 1 shared A. Quintana· 1 shared A. Vedder· 1 shared C. Letson· 1 shared C. M. Finke· 1 shared E. A. Welsh· 1 shared

Activity by Year

2022-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

U. Rix

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

The lipid phosphatase activity of PTEN dampens FRA1 expression via AKT/mTOR signaling to suppress melanoma

X. Xu, I. Bok, N. Jasani, K. Wang, M. Chadourne, O. Deng, E. A. Welsh, F. Kinose, U. Rix, F. A. Karreth

This study shows PTEN's lipid phosphatase activity suppresses melanoma by inhibiting AKT/mTOR signaling and reducing FRA1 expression.

bioRxiv · Jun 1, 2023Cancer Biology

Targeting BET Proteins downregulates miR-33a to promote synergy with PIM inhibitors in CMML

C. Letson, M. E. Balasis, H. Newman, M. Binder, A. Vedder, F. Kinose, M. Ball, T. Kruer, A. Quintana, T. L. Lasho, C. M. Finke, L. L. Almada, J. M. Grants, G. Zhang, M. E. Fernandez-Zapico, , E. Padron

This study identifies PIM inhibitors as synergistic with BET inhibitors in myeloid leukemia, showing miR-33a downregulation drives PIM1 upregulation and GM-CSF hypersensitivity as a biomarker for combination therapy.

bioRxiv · Nov 1, 2022Cancer Biology